跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
钆特酸葡胺注射液 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Gadoteric Acid Meglumine Salt Injection
Approved
化学药品
Gadoteric Acid Meglumine Salt Injection
jsc“farmak”
🇨🇳 National Medical Products Administration
Approval Date
Dec 1, 2024
Approval ID
8f0QjF3v2ro
Company
jsc“farmak”
Type
化学药品
Approval Details
Approval Id
8f0QjF3v2ro
Approval Number
国药准字HJ20240158
Generic Name
钆特酸葡胺注射液
Generic Name En
Gadoteric Acid Meglumine Salt Injection
Drug Type
化学药品
Dosage Form
注射剂
Strength
15ml:5.654g(以钆特酸葡胺计)
Reg Date
2024-12-01
Expired Date
2029-11-30
Company Name
jsc“farmak”
Company Address
63, Kyrylivska str., Kyiv, 04080, Ukraine.
Production Company Name
jsc“farmak”
Production Company Address
74, Kyrylivska str., Kyiv, 04080, Ukraine.
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 1, 2024
Approval ID
8f0QjF3v2ro
Type
化学药品
Back to NMPA Approvals